Terns Pharmaceuticals, Inc. (TERN) Other Operating Expenses (2022)
Terns Pharmaceuticals (TERN) has disclosed Other Operating Expenses for 1 consecutive years, with $17.5 million as the latest value for Q4 2023.
Terns Pharmaceuticals (TERN) has disclosed Other Operating Expenses for 1 consecutive years, with $17.5 million as the latest value for Q4 2023.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month